115 related articles for article (PubMed ID: 713282)
21. The effect of anticomplementary cobra venom factor on hyperacute rat cardiac allograft rejection.
Forbes RD; Pinto-Blonde M; Guttmann RD
Lab Invest; 1978 Nov; 39(5):463-70. PubMed ID: 366280
[TBL] [Abstract][Full Text] [Related]
22. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
Cooper PD; Sim RB
Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
[TBL] [Abstract][Full Text] [Related]
23. The role of complement activation in tumour necrosis factor-induced lethal hepatitis.
Libert C; Wielockx B; Grijalba B; Van Molle W; Kremmer E; Colten HR; Fiers W; Brouckaert P
Cytokine; 1999 Aug; 11(8):617-25. PubMed ID: 10433810
[TBL] [Abstract][Full Text] [Related]
24. Evidence for direct renal injury as a consequence of glomerular complement activation.
Boyce NW; Holdsworth SR
J Immunol; 1986 Apr; 136(7):2421-5. PubMed ID: 3950418
[TBL] [Abstract][Full Text] [Related]
25. Schistosoma mansoni: complement and cercarial tail loss during in vitro transformation.
Greenblatt HC; Eveland LK; Morse SI
Exp Parasitol; 1979 Aug; 48(1):100-8. PubMed ID: 456460
[No Abstract] [Full Text] [Related]
26. Evidence of IgG-mediated enhancement of the antibody response in vivo without complement activation via the classical pathway.
Wiersma EJ; Nose M; Heyman B
Eur J Immunol; 1990 Dec; 20(12):2585-9. PubMed ID: 2269326
[TBL] [Abstract][Full Text] [Related]
27. The effect of cobra venom factor on alternative pathway hemolytic activity in mice.
Joiner KA; Hawiger A; Gelfand JA
Immunol Commun; 1980; 9(3):277-81. PubMed ID: 7399569
[TBL] [Abstract][Full Text] [Related]
28. Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection.
Jacobs T; Andrä J; Gaworski I; Graefe S; Mellenthin K; Krömer M; Halter R; Borlak J; Clos J
Med Microbiol Immunol; 2005 May; 194(3):143-9. PubMed ID: 15378355
[TBL] [Abstract][Full Text] [Related]
29. Site-specific activation of the alternative pathway of complement. Synthesis of a hybrid molecule consisting of antibody and cobra venom factor.
Parker CJ; White VF; Falk RJ
Complement; 1986; 3(4):223-35. PubMed ID: 3643079
[TBL] [Abstract][Full Text] [Related]
30. Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system.
Van den Berg CW; Aerts PC; Van Dijk H
J Immunol Methods; 1990 Oct; 133(2):199-206. PubMed ID: 2230138
[TBL] [Abstract][Full Text] [Related]
31. Cardiotoxin from cobra venom increases the level of phosphatidylinositol 4-monophosphate and phosphatidylinositol kinase activity in two cell lines.
Lo TN; Eng SP; Jaseph LA; Beaven MA; Lo CS
Biochim Biophys Acta; 1988 Jun; 970(1):51-60. PubMed ID: 2453219
[TBL] [Abstract][Full Text] [Related]
32. Freeze-fracture study of cardiotoxin action on axonal membrane and axonal membrane lipid vesicles.
Gulik-Krzywicki T; Balerna M; Vincent JP; Lazdunski M
Biochim Biophys Acta; 1981 Apr; 643(1):101-14. PubMed ID: 7236681
[TBL] [Abstract][Full Text] [Related]
33. Reduction in alternative complement pathway mediated C3 conversion following burn injury.
Bjornson AB; Bjornson HS; Altemeier WA
Ann Surg; 1981 Aug; 194(2):224-31. PubMed ID: 7259350
[TBL] [Abstract][Full Text] [Related]
34. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
Vogel CW; Fritzinger DC; Gorsuch WB; Stahl GL
Thromb Haemost; 2015 Mar; 113(3):548-52. PubMed ID: 25031089
[TBL] [Abstract][Full Text] [Related]
35. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity.
Noel GJ; Katz S; Edelson PJ
J Infect Dis; 1988 Jan; 157(1):85-90. PubMed ID: 3257245
[TBL] [Abstract][Full Text] [Related]
36. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
van Dam AP; Hack CE
Immunology; 1987 Jun; 61(2):105-10. PubMed ID: 3596635
[TBL] [Abstract][Full Text] [Related]
37. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.
Oberholzer J; Yu D; Triponez F; Cretin N; Andereggen E; Mentha G; White D; Buehler L; Morel P; Lou J
Immunology; 1999 May; 97(1):173-80. PubMed ID: 10447729
[TBL] [Abstract][Full Text] [Related]
38. Cooperative action of complement component C3 and phagocytic effector cells in innate murine resistance to Trypanosoma lewisi.
Desai BB; Albright JW; Albright JF
Infect Immun; 1987 Feb; 55(2):358-63. PubMed ID: 3026965
[TBL] [Abstract][Full Text] [Related]
39. Isolation of rhodopsin by the combined action of cardiotoxin and phospholipase A2 on rod outer segment membranes.
Rivas EA; Le Maire M; Gulik-Krzywicki T
Biochim Biophys Acta; 1981 Jun; 644(1):127-33. PubMed ID: 7260064
[TBL] [Abstract][Full Text] [Related]
40. Modulation of delayed hypersensitivity in mice by cobra venom factor.
Bloksma N; van Dijk H; Bijlsma W; Willers J
Cell Immunol; 1979 Aug; 46(1):187-91. PubMed ID: 487442
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
